FDA expands use of CoreValve System The U.S. FDA expanded the approved use of the CoreValve System to treat certain patients who have previously had a tissue aortic valve replacement and are in need of a second one. Medtronic is based in in Minneapolis, Minnesota
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.